Cargando…
Block Copolymer Encapsulation of Disarib, an Inhibitor of BCL2 for Improved Chemotherapeutic Potential
[Image: see text] A chemical inhibitor of antiapoptotic protein, BCL2, known as Disarib, suffers poor solubility in aqueous environments; thereby limiting its potential as a chemotherapeutic agent. To overcome this limitation and enhance the therapeutic efficacy of Disarib, we have employed the enca...
Autores principales: | Joy, Reshma, Siddiqua, Humaira, Sharma, Shivangi, Raveendran, Manthra, John, Franklin, Hassan, Puthusserickal Abdulrahiman, Gawali, Santosh L, Raghavan, Sathees C., George, Jinu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical Society
2023
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10621013/ https://www.ncbi.nlm.nih.gov/pubmed/37929147 http://dx.doi.org/10.1021/acsomega.3c05802 |
Ejemplares similares
-
Acute toxicity analysis of an inhibitor of BCL2, Disarib, in rats
por: Sharma, Shivangi, et al.
Publicado: (2021) -
Acute toxicity analysis of Disarib, an inhibitor of BCL2
por: Sharma, Shivangi, et al.
Publicado: (2020) -
Unleashing a novel function of Endonuclease G in mitochondrial genome instability
por: Dahal, Sumedha, et al.
Publicado: (2022) -
Integrated Transcriptome and Metabolomic Analysis Reveal Anti-Angiogenic Properties of Disarib, a Novel Bcl2-Specific Inhibitor
por: Manjunath, Meghana, et al.
Publicado: (2022) -
Improved chemotherapeutic efficacy of injectable chrysin encapsulated by copolymer nanoparticles
por: Kim, Kyoung Mee, et al.
Publicado: (2017)